New informatics tool makes the most of genomic data
The tool was developed by members of KnowEnG, a Center of Excellence established by an NIH Big Data to Knowledge (BD2K) Initiative award to the University of Illinois in partnership with the Mayo Clinic. KnowEnG stands for Knowledge Engine for Genomics, representing the center's mission to develop analytical resources for biomedical work with genomic data. The Center is housed within the Carl R. Woese Institute for Genomic Biology at the University of Illinois.
"We all know treatment outcomes for complex diseases like cancers vary dramatically among individuals, from lacking of efficacy resulting in disease recurring to severe toxicity resulting in noncompliance in patients who cannot tolerate these life-saving drugs," said Leiwei Wang, a professor of pharmacology at the Mayo Clinic. "Therefore, it is extremely important for us to understand better of how and why patients respond differently, so that we can truly individualize their therapies by choosing the right drug at the right dose."
The researchers' first step toward this goal was a large-scale data collection effort. They assembled a panel of lab-reared tumor cells derived from a diverse set of individuals, and exposed samples of those cells to one of a set of common anticancer drugs. This allowed them to quantify the drug responses of different genetic backgrounds in a directly comparable way.
Using these data, Mayo Clinic researchers wanted to ask what characteristics of cells from each individual helped determine its unique set of responses to the drugs tested. They collected data on the "expression" of every gene in the genome--how often each gene was being read by the cell and used to create the corresponding protein that gene carries the instructions for.
The team also wanted to look at where those differences in gene expression might come from. DNA sequence surrounding genes in the genome influence when genes are expressed. So do the actions of special proteins called transcription factors, which bind to DNA and make it easier or harder for genes to be read by cellular machinery. Finally, how different regions of the long DNA strands of the genome are coiled up, the "epigenetic state" of genomic DNA also helps determine how likely a gene is to be expressed.
The team decided to collect data on all of these characteristics of their lines of cells. They had built a comprehensive dataset, but lacked something vital--an analytical tool that could use it to full advantage.
"There was no tool that would exploit all of these together," said Professor of Computer Science and Willett Faculty Scholar Saurabh Sinha, who co-directs the BD2K Center. "From the question came the data . . . then came our part, what do you do with it?"
Sinha and graduate student Casey Hanson developed an algorithm that takes in data on gene expression, genomic factors that help control gene expression, and resulting traits (such as drug response) and uses these to predict which genes are most important in determining the latter. They based their work on a tool they had previously developed named "Gene Expression in the Middle," or GENMi. Their new model, because of its ability to appropriately weight and integrate multiple sources of data, is named "probabilistic GENMi" or pGENMi.
"It's a more rigorous tool; it should automatically handle how to weight different aspects of the data when it's trying to look at many different types of data to reach a common conclusion," Sinha said. "Methodologically, that was the most challenging part, the development of the probabilistic model."
Because this tool is the first of its kind, team had to get creative to assess how well it was working--they had no prior standard of performance for comparison, and the results generated by pGENMi are the basis for further experimental work, not an endpoint.
"Our end result was testable predictions . . . a ranking of what experiments to do and verify that this transcription factor indeed has a role in regulating the response to that drug," Sinha said.
"In a lot of computer science and bioinformatics papers, there is a gold standard database to validate predictions against - but we didn't have the luxury of that," Hanson said. "We had to search a vast literature to try to find, among the myriad ways of doing so and stating that one has done so, experiments that [could] confirm our hypothesis." The team's mix of computer science and biological knowledge was what made this task possible.
Hanson and his coauthors examined whether the predictions generated by the algorithm included associations that were already confirmed by the studies he identified. The literature searches revealed examples in which transcription factors highlighted by pGENMi had been experimentally manipulated, resulting in changes in drug responsiveness. Many of the predictions generated by pGENMi were supported by previous work, making it likely that those not supported by prior work are novel but real associations.
"For example . . . we found a paper in which rapamycin [an anticancer drug] decreased GATA1 [a transcription factor's] binding with DNA. Another paper, we found that . . . rapamycin increased expression of a gene, ERCC1," Hanson said. The same paper linked the transcription factor, GATA1, to ERCC1's expression. Hanson noted that "our own experiments showed that knocking down GATA1 changed the sensitivity of cells to rapamycin," in agreement with the previous work.
To test pGENMi's results even further, the group selected transcription factors predicted to impact drug responsiveness, as well as several predicted to have little impact, and reduced their function in lab-grown cancer cells. For the majority of the TFs examined, these experimental results were consistent with pGENMi's predictions.
Although in this initial project pGENMi was used to explore the factors that influence the response of cancer cells to therapeutic drugs, its flexibility would allow for a wide range of applications.
"We have generated tools that can be used broadly by the research community. These tools will be open to anyone who might have the right data sets to both help generate hypothesis and also to help refine the algorithms," Wang said. "This is a perfect example of how expertise in complementary research areas, in this case, computational science and pharmacoproteomics, come together to make a difference."
Other news from the department science
Start-up Colossal Biosciences Joins Biorescue In Its Mission To Save The Northern White Rhino From Extinction
Colossal will assist the rescue mission by leveraging genome sequencing and gene editing methods to save the endangered species
"For the first time, we have systematically measured the size and abundance of cells across all major tissues and organs"
What's that smell? New gut microbe produces smelly toxic gas but protects against pathogens
Taurine-degrading bacteria influence intestinal microbiome
Wastewater treatment plants as drivers for the energy transition
Technical add-on module can, in principle, turn any wastewater treatment plant into a CO2 sink and decentralized methane production plant
At which age we are at our happiest
An evaluation of over 400 samples shows how subjective well-being develops over the course of a lifespan
New approach to testing for long Covid
Blood vessels in the eye altered with persistent coronavirus symptoms
Researchers create pioneering approaches for the detection of viral antigens
Sybodies: a revolution in biological recognition
New SARS-CoV-2 variant Eris on the rise
SARS-CoV-2 lineage EG.5.1 has an advantage at evading neutralizing antibodies
Does the human brain have an Achilles heel that ultimately leads to Autism?
CHOOSEn fate: one brain organoid’s tale on Autism
Co-crystal improves the water-solubility of ASA
This could benefit patients diagnosed with suspected acute myocardial infarction
Observing nanoparticles with unprecedented precision
Illuminated: Researchers investigate new physical phenomena on the nanoscale with microstructured fibers
Falling Walls announces Science Breakthrough of the Year 2023 laureates
“These outstanding breakthroughs will change the face of the world and impressively prove what ingenuity, curiosity and courage can achieve”
Most read news
Cells with an ear for music release insulin
For the first time, researchers are using music, including Queen's global hit "We will rock you," to stimulate insulin release from cells
"Anti-obesity drugs" normalises brain in obesity
Anti-obesity drug improves associative learning in people with obesity
Microbe of the Year 2023: Bacillus subtilis – for health and technology
Already, Bacillus subtilis is indispensable in many industries, and many more innovations are expected
Younger generation gets sick earlier and more often than older generation
In spite of their advanced age, they are in the middle of life, healthy, active and mentally alert – they are referred to as the “young old”
How sleep deprivation can harm the brain
Sleep deprivation decreases the amount of a factor that protects neurons
A whole new order of bacteria could hold the key to improving biogas production
The discovery was made by researchers from Germany, Spain and the Netherlands
How to inactivate common cold viruses
In the cold season, cold viruses are everywhere. But we can do something about it
How minimal genetic differences can turn healthy food into a deadly danger
You are what you eat - this old saying could take on a new dimension according to latest research results
New approach to testing for long Covid
Blood vessels in the eye altered with persistent coronavirus symptoms
More news from our other portals
Major breakthrough in the development of electric vehicle batteries
New study finds ways to suppress lithium plating in automotive batteries for faster charging electric vehicles
Blender Bites launches at Walmart USA
The products are to be introduced in about 1,600 stores across the country
Benchtop NMR spectroscopy can accurately analyse pyrolysis oils
More accessible analysis could help develop the potential of bio-oils as an alternative to fossil fuels
Green methanol for shipping and industry: € 10.4 Mio. for the "Leuna100" project
A consortium of two Fraunhofer institutes, DBI-Gastechnologisches Institut Freiberg, Technical University of Berlin and C1 makes industrial history at the Leuna site
Clean water from fog
A property known as photocatalytic memory ensures that this also functions when skies are overcast and at night
Green, sweet and crisp - New apple variety Pia41 approved
The apple bred at the Julius Kühn Institute receives variety protection
Research shows table salt could be the secret ingredient for better chemical recycling
Table salt as the key to the plastics recycling revolution?
Sugar: Small increase in production despite record prices
EU sugar market more than in need of reform to keep medium-sized processing companies competitive
Graphene discovery could help generate hydrogen cheaply and sustainably
Microscopic insights into electrochemical interfaces
Stanford study shows how the meat and dairy sector resists competition from alternative animal products
Scientists use quantum device to slow down simulated chemical reaction 100 billion times
What happens in femtoseconds in nature can now be observed in milliseconds in the lab
New battery holds promise for green energy
Redox-flow battery eliminates costly and inefficient membrane
Fondant under the magnifying glass
New insights into the properties of sweet coating: The results could be used to optimize the industrial production process in the future
Leipzig-based start-up converts CO₂ into green chemicals with patented plasma catalysis
CO₂ recycling as a useful complement to carbon capture and storage
A microchip for Parmigiano Reggiano cheese
Consorzio del Parmigiano Reggiano, p-Chip Corporation, and Kaasmerk Matec Partner to Launch Breakthrough in Food-Safe Digital Tracking Technology
Cleaning water with ‘smart rust’ and magnets
New method for pollutants such as crude oil, glyphosate, microplastics and hormones
A Second Life for Electric Car Batteries
Scientists develop a decision model for retired lithium-ion batteries